cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase.

Article Details

Citation

Guan G, Dai P, Shechter I

cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase.

Arch Biochem Biophys. 2003 Sep 15;417(2):251-9.

PubMed ID
12941308 [ View in PubMed
]
Abstract

myo-Inositol 1-phosphate synthase (EC 5.5.1.4) (IPS) is a key enzyme in myo-inositol biosynthesis pathway. This study describes the molecular cloning of the full length human myo-inositol 1-phosphate synthase (hIPS) cDNA, tissue distribution of its mRNA and characterizes its gene expression in cultured HepG2 cells. Human testis, ovary, heart, placenta, and pancreas express relatively high level of hIPS mRNA, while blood leukocyte, thymus, skeletal muscle, and colon express low or marginal amount of the mRNA. In the presence of glucose, hIPS mRNA level increases 2- to 4-fold in HepG2 cells. hIPS mRNA is also up-regulated 2- to 3-fold by 2.5 microM lovastain. This up-regulation is prevented by mevalonic acid, farnesol, and geranylgeraniol, suggesting a G-protein mediated signal transduction mechanism in the regulation of hIPS gene expression. hIPS mRNA expression is 50% suppressed by 10mM lithium ion in these cells. Neither 5mM myo-inositol nor the three hormones: estrogen, thyroid hormone, and insulin altered hIPS mRNA expression in these cells.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Inositol-3-phosphate synthase 1Q9NPH2Details